Variable RNA sequencing depth impacts gene signatures and target compound robustness – case study examining brain tumour (glioma) disease progression

Available treatments for glioma have limited effectiveness rendering this a disease of poor clinical outcome. Gene expression profiling can uncover the biological mechanisms underlying disease, information that is crucial for drug development or repurposing. RNA sequencing (RNA-seq) is routinely use...

詳細記述

保存先:
書誌詳細
出版年:Neuro Oncol
主要な著者: Stupnikov, Dr Alexey, McInerney, Dr Caitríona, O’reilly, Dr Paul, Roddy, Aideen, Dunne, Dr Philip, Gilmore, Mr Alan, Ellis, Dr Hayley, Flannery, Mr Tom, Healy, Dr Estelle, Mcintosh, Dr Stuart, Savage, Dr Kienan, Salto-Tellez, Prof Manuel, Emmert-streib, Dr Frank, Kurian, Dr Kathreena, Prise, Prof Kevin, McArt, Dr Darragh
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2018
主題:
Abstracts
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6168872/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy130.067
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料